Literature DB >> 17345120

Special variants of differentiated thyroid cancer: does it alter the extent of surgery versus well-differentiated thyroid cancer?

Tobias Carling1, Idris T Ocal, Robert Udelsman.   

Abstract

INTRODUCTION: Recently, more aggressive variants of so-called well-differentiated thyroid carcinomas have been identified such as the tall cell variant, columnar cell variant, diffuse sclerosing variant, insular carcinoma, and Hürthle cell (oncocytic, oxyphilic) carcinomas.
METHODS: An evidence-based review was performed to identify the optimal treatment recommendations for these thyroid cancers of intermediate differentiation.
CONCLUSIONS: Although some variation exists within the group, aggressive surgical and medical management are recommended for these neoplasias. Any such recommendations should, however, be viewed in the light of the fact that the current literature mainly consists of case reports, case series, and limited reviews. The clinical presentation, pathophysiology, diagnosis, and surgical and medical management for these thyroid cancers with intermediate differentiation are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17345120     DOI: 10.1007/s00268-006-0837-3

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  34 in total

1.  Randomized prospective evaluation of frozen-section analysis for follicular neoplasms of the thyroid.

Authors:  R Udelsman; W H Westra; P I Donovan; T A Sohn; J L Cameron
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

2.  Tall cell variant of papillary thyroid carcinoma: cytologic features and differential diagnostic considerations.

Authors:  T Bocklage; J P DiTomasso; I Ramzy; M L Ostrowski
Journal:  Diagn Cytopathol       Date:  1997-07       Impact factor: 1.582

3.  Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics.

Authors:  M D Tronko; T I Bogdanova; I V Komissarenko; O V Epstein; V Oliynyk; A Kovalenko; I A Likhtarev; I Kairo; S B Peters; V A LiVolsi
Journal:  Cancer       Date:  1999-07-01       Impact factor: 6.860

Review 4.  Well-differentiated thyroid cancer.

Authors:  G H Jossart; O H Clark
Journal:  Curr Probl Surg       Date:  1994-12       Impact factor: 1.909

5.  Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid.

Authors:  M Albareda; M Puig-Domingo; S Wengrowicz; J Soldevila; X Matias-Guiu; A Caballero; A Chico; A De Leiva
Journal:  Thyroid       Date:  1998-05       Impact factor: 6.568

6.  Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma.

Authors:  H L Evans
Journal:  Am J Clin Pathol       Date:  1986-01       Impact factor: 2.493

Review 7.  The demise of follicular carcinoma of the thyroid gland.

Authors:  V A LiVolsi; S L Asa
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

Review 8.  Radioiodine therapy for thyroid cancer.

Authors:  D C Sweeney; G S Johnston
Journal:  Endocrinol Metab Clin North Am       Date:  1995-12       Impact factor: 4.741

9.  Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases.

Authors:  J Soares; E Limbert; M Sobrinho-Simões
Journal:  Pathol Res Pract       Date:  1989-08       Impact factor: 3.250

Review 10.  Hürthle cell carcinoma: clinic-pathological and biological aspects.

Authors:  Maria Luisa Carcangiu
Journal:  Tumori       Date:  2003 Sep-Oct
View more
  15 in total

1.  Diagnostic significance of elevated expression of HBME-1 in papillary thyroid carcinoma.

Authors:  Yang-Jing Chen; Rui-Min Zhao; Qian Zhao; Bai-Ya Li; Qing-Yong Ma; Xiao Li; Xia Chen
Journal:  Tumour Biol       Date:  2016-01-07

2.  Ninety-four cases of encapsulated follicular variant of papillary thyroid carcinoma: A name change to Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features would help prevent overtreatment.

Authors:  Lester Dr Thompson
Journal:  Mod Pathol       Date:  2016-04-22       Impact factor: 7.842

Review 3.  Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.

Authors:  Cristina Pizzimenti; Vincenzo Fiorentino; Antonio Ieni; Maurizio Martini; Giovanni Tuccari; Maria Lentini; Guido Fadda
Journal:  Endocrine       Date:  2022-07-21       Impact factor: 3.925

Review 4.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

5.  Prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis.

Authors:  Scharukh Jalisi; Tiffiny Ainsworth; Michael Lavalley
Journal:  J Thyroid Res       Date:  2010-07-26

6.  Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.

Authors:  Eric J Kuo; Paolo Goffredo; Julie A Sosa; Sanziana A Roman
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

Review 7.  Active Surveillance of Thyroid Microcarcinomas: a Critical View.

Authors:  Claudio R Cernea; Leandro Luongo Matos; Cecília Eugênio; Giovanna Mattos Ferreira; Yasmin Sa Cerqueira; Ana Kober N Leite; Felipe A B Vanderlei; Dorival de Carlucci; Renato N Gotoda; Flávio C Hojaij; Vergilius J F Araújo-Filho
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

8.  Pulmonary tumor thrombotic microangiopathy with thrombus in pulmonary artery caused by diffuse sclerosing variant of thyroid papillary adenocarcinoma: A case report.

Authors:  Masahiro Yoshida; Shiro Adachi; Itsumure Nishiyama; Kenichiro Yasuda; Ryo Imai; Yoshihisa Nakano; Yuta Tsuyuki; Deoksu Kim; Takahisa Kondo; Toyoaki Murohara
Journal:  Pulm Circ       Date:  2022-01-12       Impact factor: 2.886

9.  Propensity score matching analysis of the prognosis for the rare insular subtype of thyroid cancer based on SEER database.

Authors:  Yan Liu; Zeming Liu; Qiuyang Zhao; Teng Hua; Shuqi Chi; Tao Huang; Hongbo Wang
Journal:  Oncotarget       Date:  2017-10-11

10.  Clinical behaviors of rare variants of papillary thyroid carcinoma are associated with survival: a population-level analysis.

Authors:  Chenghao Jiang; Tong Cheng; Xucai Zheng; Shikai Hong; Song Liu; Jianjun Liu; Jing Wang; Shengying Wang
Journal:  Cancer Manag Res       Date:  2018-03-09       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.